POSTPONED- Comprehensive Management of Advanced Head and Neck Skin Cancer Symposium

Saturday, October 12, 2019


This conference has already taken place.


James Cancer Hospital & Solove Research Institute - Wasserstrom Room (James L035) - Columbus, OH
1 Day Conference October 12th, 2019
5.00 AMA PRA Category 1 Credit Hours

Description

Skin cancer is the most common type of cancer in the United States, affecting nearly 1 in 5 people at some point during their lifetime. Overall incidence rates of both melanoma and nonmelanoma skin cancers have been increasing, with millions of Americans affected by this disease every year. While skin cancers can occur anywhere on the body, the head and neck region is particularly susceptible. When cancers do occur on the skin of the face or neck, the deformity resulting from the cancer and the treatment can be significant from both an aesthetic and functional viewpoint. When detected and treated promptly, most nonmelanoma skin cancers are highly curable. Melanoma, on the other hand, is the type of skin cancer that results in the highest mortality.
With so much at stake for patients with this disease, it is imperative that physicians are armed with the most current recommendations and have access to the appropriate specialists, particularly for the advanced skin cancers of the head and neck. In recent years, there have been advances in detection and surveillance methods and technology, surgical management of melanoma and nonmelanoma skin cancers, reconstructive options for complex cancer defects, radiation therapy for select skin cancer patients and chemotherapy/biologic treatments options for these patients.
With regard to detection and surveillance, advances in patient education and technology have allowed for earlier detection of primary and recurrent skin cancers which often results in less invasive treatment and higher cure rates.
Research published in recent years has resulted in updated guidelines for melanoma and some nonmelanoma skin cancers. Surgical recommendations have evolved to include sentinel node biopsies for many of these cancers, as an example.

Reconstructive surgery after head and neck skin cancer removal has progressed as well. Reconstructive surgeons have accepted the challenge of reconstructing not only the skin, but also the cartilage, bone, muscle and nerves that are involved with advanced skin cancers of the head and neck. New surgical techniques and adjuvant measures have created more opportunity to achieve effective aesthetic and functional outcomes.
Beyond surgery, the fields of radiation and medical oncology have produced new and exciting ways to effectively treat these cancers. When and how to treat advanced skin cancers with radiation is a key component of overall management, and advances in biologic therapies have allowed for some patients to avoid the need for primary surgical therapy and the morbidities that accompany it.
The Comprehensive Management of Advanced Head and Neck Skin Cancer Symposium will consist of live presentations and open panel discussions. The course will feature experienced OSU faculty members specialized in Facial Plastic and Reconstructive Surgery, Otolaryngology, and specially selected guest speakers who are considered experts in their field. The discussions will consist of the latest technologies, resources, and advancements in head and neck skin cancer surveillance and treatments. The format of this course is appropriate because it is targeting a broad audience with valuable information and including interaction with panel discussions. All of which will influence provider performance in the future.
The Comprehensive Management of Advanced Head and Neck Skin Cancer Symposium is designed to further educate the target audience on the latest trends in detecting and treating head and neck skin cancer.

Dates and Times

Start: 10/12/2019 12:00 AM
End: 10/12/2019 12:00 AM

Objectives

At the conclusion of this activity, learners should be able to:

Recognize the presentation and diagnostic workup of the most common skin malignancies

Identify the differences in pathology and behavior of these malignancies

Explain the comprehensive, multi-disciplinary approach to management of these malignancies

Describe the complexities that exist in reconstructing the head and neck after resection of these malignancies

Pricing

Tier Price
Registration $60.00

Speakers

  • Dr. Mark Bechtel, MD
    • POSTPONED- Comprehensive Management of Advanced Head and Neck Skin Cancer Symposium
  • Dr. Dukagjin Blakaj, MD
    • POSTPONED- Comprehensive Management of Advanced Head and Neck Skin Cancer Symposium
  • Dr. David Carr, MD
    • POSTPONED- Comprehensive Management of Advanced Head and Neck Skin Cancer Symposium
  • Dr. Raymond Cho, MD
    • POSTPONED- Comprehensive Management of Advanced Head and Neck Skin Cancer Symposium
  • Dr. Catherine Chung, MD
    • POSTPONED- Comprehensive Management of Advanced Head and Neck Skin Cancer Symposium
  • Dr. Stephen Kang, MD
    • POSTPONED- Comprehensive Management of Advanced Head and Neck Skin Cancer Symposium
  • Dr. Leslie Kim, MD
    • POSTPONED- Comprehensive Management of Advanced Head and Neck Skin Cancer Symposium
  • Dr. Stephen Nogan, MD
    • POSTPONED- Comprehensive Management of Advanced Head and Neck Skin Cancer Symposium
  • Dr. Llana Pootrakul, MD
    • POSTPONED- Comprehensive Management of Advanced Head and Neck Skin Cancer Symposium
  • Dr. Nolan Seim, MD
    • POSTPONED- Comprehensive Management of Advanced Head and Neck Skin Cancer Symposium
  • Dr. Hiral Shah, MD
    • POSTPONED- Comprehensive Management of Advanced Head and Neck Skin Cancer Symposium
  • Dr. Natalie Spaccarelli, MD
    • POSTPONED- Comprehensive Management of Advanced Head and Neck Skin Cancer Symposium

Location

James Cancer Hospital & Solove Research Institute - Wasserstrom Room (James L035)
460 West 10th Avenue
Columbus, OH 43210

Accreditation Statement

The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University designates this live activity for a maximum of 5.00 AMA PRA Category 1 Credit(s) . Physicians should only claim credit commensurate with the extent of their participation in the activity.